The MITT group has been founded in 2018 in Italy, to promote multidisciplinary partnership among physicians with different expertise who share the interest in MITT and to improve the clinical, diagnostic, and therapeutic management of benign and malignant thyroid and parathyroid glands diseases.
During the 2024 MITT meeting, the present guidelines on both benign and malignant thyroid disease management will be presented, and the most widely used techniques for ablation will be presented by renowned experts in the field. Also, the most updated evidence on the application of MITT in
